Index to Consolidated Financial Statements Page To the Board of Directors and Stockholders of Agilent Technologies, Inc. Basis for Opinions As described in Management's Report on Internal Control Over Financial Reporting, management has excluded BIOVECTRA from its assessment of internal control over financial reporting as of October 31, 2024 because it was acquired by the Company in a purchase business combination during 2024. We have also excluded BIOVECTRA from our audit of internal control over financial ...